Solventum (SOLV) EPS (Weighted Average and Diluted) (2023 - 2026)

Solventum has reported EPS (Weighted Average and Diluted) for 4 years, with the latest figure at $0.07 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 91.03% year-over-year to $0.07; the trailing twelve-month figure through Mar 2026 stood at $8.15 (up 275.58% YoY), and the FY2025 full-year result was $8.88, up 221.74% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.07, down from $0.35 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $7.22 in Q3 2025, with the low at $0.07 in Q1 2026.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.5 across 4 years, with a median of $0.78 in 2025.
• Annual changes were most pronounced in 2025 — EPS (Weighted Average and Diluted) soared 931.43% — and 2026, when it slumped 91.03%.
• Solventum's EPS (Weighted Average and Diluted) stood at $1.57 in 2023, then tumbled by 88.54% to $0.18 in 2024, then soared by 94.44% to $0.35 in 2025, then slumped by 80.0% to $0.07 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.07 (Q1 2026), $0.35 (Q4 2025), and $7.22 (Q3 2025), per Business Quant data.